Schedule 13G ownership disclosure

REGENXBIO Inc

Common Stock · CUSIP: 75901B107

Event date: 2024-12-31

Filing-level shares
2,985,952
Percent of class
6.02%
  • The Vanguard Group

    Shares: 2,985,952 · Class: 6.02%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000211
Form type
SCHEDULE 13G/A
Filer
REGENXBIO Inc.
CIK
CIK 1590877
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub